Clinical and Experimental Hepatology
Published by Termedia Publishing House Ltd.
ISSN : 2392-1099 eISSN : 2449-8238
Abbreviation : Clin. Exp. Hepatol.
Aims & Scope
Clinical and Experimental Hepatology – quarterly of the Polish Association for Study of Liver – is a scientific and educational, peer-reviewed journal publishing original and review papers describing clinical and basic investigations in the field of hepatology.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 1.7 |
2024 | 1.50 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.481 |
Quartile
Year | Value |
---|---|
2024 | Q3 |
h-index
Year | Value |
---|---|
2024 | 23 |
Journal Rank
Year | Value |
---|---|
2024 | 11961 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 269 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 800.00 EUR. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Epidemiology of gallbladder cancer
Citation: 241
Authors: Prashanth, Tagore, Krishna Chaitanya, Adam
-
Ammonia-induced mitochondrial dysfunction and energy metabolism disturbances in isolated brain and liver mitochondria, and the effect of taurine administration: relevance to hepatic encephalopathy treatment
Citation: 75
Authors: Hossein, Akram, Reza, Mahdi, Mohammad Mehdi
-
Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease
Citation: 61
Authors: Monika, Iwon, Michał
-
The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases
Citation: 60
Authors: Kamila, Ewa, Anna
-
An updated review of cystic hepatic lesions
Citation: 53
Authors: Prashanth, Tagore, Pradhyumna, Jeffrey Pradeep
-
Evaluation of serum interleukin-6 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis
Citation: 48
Authors: Ebrahim, Mazaher, Masoud
-
AÂ systematic review of the present and future of non-alcoholic fatty liver disease
Citation: 42
Authors: Christiana, Georgia, Nicholas, Joanna, Krzysztof
-
Taurine supplementation abates cirrhosis-associated locomotor dysfunction
Citation: 40
Authors: Reza, Akram, Vahid, Mohammad Mehdi, Hossein
-
SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review
Citation: 37
Authors: Michael, David, Irsan, Monica